- Home
- GALT vs III Comparison
GALT vs III Comparison
Compare GALT & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- III
- Stock Information
- Founded
- GALT 2000
- III 2006
- Country
- GALT United States
- III United States
- Employees
- GALT N/A
- III N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- III Professional Services
- Sector
- GALT Health Care
- III Consumer Discretionary
- Exchange
- GALT Nasdaq
- III Nasdaq
- Market Cap
- GALT 232.3M
- III 249.2M
- IPO Year
- GALT N/A
- III 2007
- Fundamental
- Price
- GALT $5.37
- III $5.24
- Analyst Decision
- GALT Strong Buy
- III Buy
- Analyst Count
- GALT 3
- III 1
- Target Price
- GALT $6.00
- III $5.50
- AVG Volume (30 Days)
- GALT 301.1K
- III 180.9K
- Earning Date
- GALT 11-12-2025
- III 11-06-2025
- Dividend Yield
- GALT N/A
- III 3.44%
- EPS Growth
- GALT N/A
- III N/A
- EPS
- GALT N/A
- III 0.16
- Revenue
- GALT N/A
- III $240,201,000.00
- Revenue This Year
- GALT N/A
- III N/A
- Revenue Next Year
- GALT N/A
- III $5.10
- P/E Ratio
- GALT N/A
- III $33.39
- Revenue Growth
- GALT N/A
- III N/A
- 52 Week Low
- GALT $0.73
- III $2.95
- 52 Week High
- GALT $6.55
- III $5.30
- Technical
- Relative Strength Index (RSI)
- GALT 68.40
- III 63.42
- Support Level
- GALT $3.93
- III $5.10
- Resistance Level
- GALT $4.35
- III $5.29
- Average True Range (ATR)
- GALT 0.38
- III 0.13
- MACD
- GALT 0.10
- III 0.00
- Stochastic Oscillator
- GALT 55.47
- III 82.86
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About III Information Services Group Inc.
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.